Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evident Technologies is a nanotechnology company specializing in the development and commercialization of semiconductor nanocrystals, commonly known as quantum dots. The company's proprietary EviDot technology provides high-performance fluorescent labels for use in life science research, including cellular imaging, flow cytometry, and molecular diagnostics. Beyond healthcare, Evident Technologies applies its nanomaterials to solid-state lighting, telecommunications, and solar energy sectors. Their products are designed to offer superior brightness and photostability compared to traditional organic dyes. In 2016, the company notably sold its quantum dot patent portfolio to Samsung Electronics, while continuing to serve the scientific research community with its advanced material solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evident Technologies.